The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $ last updated September 3, at PM EDT. Q. Does Bolt Biotherapeutics (BOLT) pay a. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and. Stock Information · Stock Quote & Chart · Analyst Coverage · Corporate Governance Boltbody TM ISAC at the Society for Immunotherapy of Cancer (SITC) 39th. BOLT Stock Overview ; Summary of all time highs, changes and price drops for Bolt Biotherapeutics. Historical stock prices ; 52 Week High, US$ ; 52 Week Low.
So be sure to compare a stock to its industry's growth rate when sizing up stocks from different groups. Dianthus Therapeutics, Inc. (DNTH) Reports Q2. Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Bolt Biotherapeutics' pipeline. Bolt Biotherapeutics Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Market Cap Chart Since the IPO on February 5, , Bolt Biotherapeutics's market cap has decreased from $M to $M, a decrease of %. That is a. NASDAQ: BOLT. Bolt Biotherapeutics Inc Stock ; BOLT Price · $ ; Market Cap · $M ; 52 Week Low · $ ; 52 Week High · $ ; P/E · x. View the BOLT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bolt Biotherapeutics. Bolt Biotherapeutics Inc BOLT:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High A high-level overview of Bolt Biotherapeutics, Inc. (BOLT) stock. Stay up The company was formerly known as Bolt Therapeutics, Inc. and changed its. Out of 3 analysts, 0 (0%) are recommending BOLT as a Strong Buy, 1 (%) are recommending BOLT as a Buy, 2 (%) are recommending BOLT as a Hold, 0 (0%). Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Stock Price. Open: Prev. Close: Low/Hi: - Week: - ; Volume. Stock: , Day Avg: , ; Volatility. Today's Stock.
16, (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company pioneering novel immuno-oncology therapeutics. Stock Information. Stock Quote. NASDAQ GS: BOLT. $ August 30, PM EDT. Change; 0 (%): Volume; 0: Today's Open; Previous Close; $ Bolt Biotherapeutics, Inc. operates as a biotechnology company. The Company develops immune-stimulating antibody conjugates, a new class of cancer therapeutics. On Friday 08/30/ the closing price of the Bolt Biotherapeutics Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/30/ Bolt Biotherapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Bolt Biotherapeutics market cap as of August 27, is $B. Compare BOLT With Other Stocks Sarepta Therapeutics (SRPT), United States, $B. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. View Bolt Biotherapeutics, Inc. BOLT stock quote prices, financial information, real-time forecasts, and company news from CNN. According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Bolt Biotherapeutics is $
Since then, BOLT stock has decreased by % and is now trading at $ View the best growth stocks for here. How were Bolt Biotherapeutics' earnings. Key Data ; Exchange. NASDAQ-GS ; Sector. Health Care ; Industry. Biotechnology: Pharmaceutical Preparations ; 1 Year Target. $ ; Average Volume. , Bolt Biotherapeutics Inc ; AM, Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting manager-wb.ru Elite ; AM · Bolt. As of Jul the stock price of Bolt Biotherapeutics is $ What is the current market cap of Bolt Biotherapeutics? The current market capitalization of. Track Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote, latest community messages, chart, news and other stock related information.
BOLT stock bolt Bolt Biotherapeutics Top stocks to buy in November
Bolt Biotherapeutics (BOLT) Stock Performance ; Bolt Biotherapeutics (BOLT). , ; S&P Small-Cap , ; BSE Sensex. , Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination. We were incorporated under the laws of Delaware under the name Bolt Therapeutics, Inc. The transfer agent and registrar for our common stock is American Stock.
THESE STOCKS WILL GO INSANE TOMORROW
Where Do I Promote My Youtube Channel | Best Zero Foreign Transaction Fee Card